Advertisement
News
Advertisement

Consumer Information on: Ethicon? OMNEX? Surgical Sealant - P060029

Fri, 06/11/2010 - 7:42am
U.S. Food & Drug Administration

Picture of Ethiconâ„¢ OMNEXâ„¢ Surgical SealantThis is a brief overview of information related to FDAâ??s approval to market this product.  See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDAâ??s approval.

 

Product Name:  Ethicon OMNEXâ?¢ Surgical Sealant

Manufacturer:  Ethicon, Inc, a Johnson and Johnson Company.

Address:  Route 22 West, Somerville, NJ 08876

Approval Date:  June 3, 2010

Approval Letter:  http://www.accessdata.fda.gov/cdrh_docs/pdf6/P060029a.pdf

 

What is it?  Ethiconâ?¢ OMNEXâ?¢ is a medical sealant that is used to help stop leaks in blood vessels.  It is made of two synthetic components called cyanoacrylate monomers, and does not include any human or animal materials.

 

How does it work? The two components are mixed together and applied during surgery to form a strong flexible film that seals gaps and holes in the patientâ??s blood vessels or grafts.

 

When is it used?  Ethiconâ?¢ OMNEXâ?¢ is used to help seal leaks around sutures in natural or artificial blood vessels. 

 

What will it accomplish? In a clinical research study, immediately after treatment, leaking suture areas were successfully sealed in 55% patients treated with Ethiconâ?¢ OMNEXâ?¢, as compared to only 10% of patients who received another kind of treatment to stop bleeding.  After 10 minutes, leaking suture areas were successfully sealed in 93% of patients treated with Ethiconâ?¢ OMNEXâ?¢, as compared to 42% of patients who received another kind of treatment to stop bleeding. 

 

When should it not be used?  Ethiconâ?¢ OMNEXâ?¢ should not be used:

  • in patients allergic to cyanoacrylate or formaldehyde
  • inside blood vessels
  • as a replacement for sutures or staples

 

The safety and performance of Ethiconâ?¢ OMNEXâ?¢ have not been determined in children and pregnant women or when used in quantities greater than 1000 microliters per patient.

 

Additional information: 

  • Summary of Safety and Effectiveness and labeling are available online.

 

    

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading